Tags

Phase II BET

Zhejiang Wenda Pharma reports Phase II BET inhibitor trial data

Zhejiang Wenda Pharma reports Phase II BET inhibitor trial data

October 26, 2026 | 15:57
Zhejiang Wenda Pharma published Phase II clinical trial results at ESMO 2026 for oral BET inhibitor NHWD-870 HCl in patients with advanced NUT carcinoma.

Latest News

Vietnam and Belgium to expand trade and investment projects

Vietnam and Belgium to expand trade and investment projects

CEO 500 opens up cooperation opportunities in FDI and technology

CEO 500 opens up cooperation opportunities in FDI and technology

New liquidity rules set standards for banks

New liquidity rules set standards for banks

SUNHOUSE wins second consecutive APEA Corporate Excellence Award

SUNHOUSE wins second consecutive APEA Corporate Excellence Award

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia Ansarada
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society CSR Swing for the Kids
World News
virs-publications-vir
timeout-vn
ptbv2020